Interesting links to CML foundation & Swine Flu

[Guest guest]

http://www.cml-foundation.org/web-links

************************************

October 2008.............. " RGB-286638 is a novel multi-targeted protein kinase

inhibitor with activity in chronic myelogenous leukemia (CML) models, " (Abstract

#578). The data presented demonstrate that the RGB-286638 small molecule has

potent activity against chronic myeloid leukemia (CML) in in vivo models that

are resistant to imatinib (Gleevec®) and to dasatinib (Sprycel®), the current

standards of care for treating this form of cancer. Additionally, RGB-286638 has

been shown in vitro to be active against a number of families of protein kinases

that are important for the proliferation of cancer cells. RGB-286638 is expected

to enter Phase 1 clinical testing this year. "

http://www.medicalnewstoday.com/articles/126979.php

****************************************************

" As NHS hospitals face an even tougher winter than usual managing the rise in

demand for beds alongside the second wave of swine flu, an influential group of

doctors, scientists and patient representatives has called for the early

discharge of appropriate MRSA patients to prevent a rise in MRSA infection

rates. "

http://www.medicalnewstoday.com/articles/168234.php

********************************************************

" TheraDoc®, the leading provider of clinical decision support technology in

healthcare, announced that it has started beta testing of a new computerized

patient surveillance tool that will help hospitals monitor and manage screening

programs for multidrug-resistant organisms (MDROs), such as

methicillin-resistant Staphylococcus aureus, or MRSA, which every year kills

more people in the United States than AIDS. "

http://www.medicalnewstoday.com/articles/167705.php

FYI,

Lottie Duthu